The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  July 2018 Next

Medicinal Chemistry Residential School

11 - 16 June 2017, Loughborough, UK

The Royal Society of Chemistry Medicinal Chemistry Residential School will cover topics of interest to drug discovery researchers, helping to increase understanding of the factors governing modern drug discovery from the initial concept through to translational science and intellectual property. Established since 1981, our Residential School has trained many of the world’s leading medicinal chemists working in the pharmaceutical industry and academic research institutes.

Who should attend?

The school is designed for graduate and post-doctoral chemists with 1-5 years’ experience in the field of drug research. Drug discovery is an interdisciplinary subject so delegates from biological or computational backgrounds will benefit from attendance at the school.
In addition, final year PhD students from pharmaceutical or organic chemistry contemplating a career in drug discovery are also encouraged to attend.

Course content

The course includes the following topics:

  •     Target Validation
  •     Computational Chemistry
  •     Biological Mechanisms
  •     Pharmacokinetics and Drug Metabolism
  •     Screening of New Compounds
  •     Patents
  •     Molecular Biology in Medicinal Chemistry
  •     Exploiting a Chemical Lead
  •     Combinatorial Chemistry and Molecular Diversity
  •     Case Histories of Drug Discovery
  •     Toxicology in Drug Discovery
  •     Pharmaceutical Considerations in Drug Development
  •     Structure-guided Drug Design
  •     Physical Properties and Quantitative Structure-Activity Relationships
  •     Hints and Tips in Medicinal Chemistry

Course organisers

Dr Andy Davis (Course Leader) AstraZeneca, United Kingdom
Dr Simon Ward (Course Leader) University of Sussex, United Kingdom
Dr Kathleen Too, Royal Society of Chemistry, United Kingdom

Key deadlines

Poster abstract deadline: 7 May 2017
Early bird registration: 9 April 2017
Standard registration: 7 May 2017

More information about the course available on the webpage : http://rsc.li/med-chem-2017


Medicinal Chemistry Residential School

17- 21 June 2013, Loughborough University, UK

Introduction

This school will take place at the Holywell Park Conference Centre, Loughborough University. This course is highly valued by the medicinal chemistry community, and has trained some of the world's leading medicinal chemists in the pharmaceutical industry. Its purpose is to aid the transition from synthetic chemistry to medicinal chemistry.

Who should attend?

The course is directed primarily at graduate and post doctoral chemists with 1-5 years experience in the field of drug research. Final year PhD students in pharmacy and organic chemistry contemplating a career in medicinal chemistry will find the course of use, and a number of bursaries are available for full-time students in membership of the RSC. 

Objectives

The objectives of the course are to highlight the current understanding of the factors governing modern drug discovery.  Although the course will focus on general principles rather than specific diseases, there will be accounts of case histories of drug discovery illustrating modern methodology. 

Method

Teaching will be by a series of lectures from experts in the field together with tutorials covering the main themes of the course. These give participants the opportunity to put their learning into practice. Throughout the week course tutors will be available for informal discussion. The programme also includes an evening lecture from a distinguished speaker. There will be a broad range of academic and industrial medicinal chemists attending in an environment suited to networking. 

Course content

The course will include the following topics:

  • Computational Chemistry
  • Biological Mechanisms
  • Pharmacokinetics and Drug Metabolism
  • Screening of New Compounds
  • Patents
  • Molecular Biology in Medicinal Chemistry
  • Exploiting a Chemical Lead
  • Combinatorial Chemistry and Molecular Diversity
  • Case Histories of Drug Discovery
  • Toxicology in Drug Discovery
  • Pharmaceutical Considerations in Drug Development
  • Structure-guided Drug Design
  • Physical Properties and Quantitative Structure-Activity Relationships
  • Hints and Tips in Medicinal Chemistry          

Course organisers

Dr Andy Davis (course leader) AstraZeneca
Dr Anne Horan (course secretary) Royal Society of Chemistry

A full list of course tutors can be seen on the Teaching Staff page.

More information about the course available on the webpage : http://www.rsc.org/conferencesandevents/rscconferences/medchem-training/index.asp?utm_content=EFMC&utm_source=non-rsc-website&utm_medium=link&utm_campaign=mkt-jrp-2013medsch


M T W T F S S
25 26 27 28 29 30 01
02 03 04 05 06 07 08
09 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 01 02 03 04 05
All events   |  Future events

Job portal

27/04/2018
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck